Nephrology

Filter

Revolutions in IgAN therapy

9 Mins

September 2025

This symposium at ERA 2025 explored the evolving treatment landscape in immunoglobulin A nephropathy (IgAN) and novel, targeted therapies…

Revolutions in IgAN therapy

This symposium at ERA 2025 explored the evolving treatment landscape in immunoglobulin A nephropathy (IgAN) and novel, targeted therapies…

Acute Kidney Injury and Nephrolithiasis in Sarcoidosis After Vitamin D Supplementation

Sarcoidosis is a multisystemic disorder of unknown aetiology, characterised by fibrosis and non-necrotising granuloma deposition…

Interview: Professor Patrick Maxwell

Patrick Maxwell, Regius Professor of Physic and Head of the School of Clinical Medicine at the University of Cambridge, UK took us through…

25 Jun 2025

Why Are You Still Avoiding PD in Older Adults? An Interactive Case Study

For elderly patients, survival duration between hemodialysis and peritoneal dialysis, even when statistically significant, is usually in…

Characterising Drug-Associated Nephrolithiasis

Kidney stones are the most common condition affecting the urinary system, impacting approximately 8–12% of the global population…

Lupus Vasculitis, a Rare Diagnosis and a Therapeutic Challenge

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may manifest with…

Targeting IgAN with Sparsentan + a SGLT2i

IgA nephropathy (IgAN) can impact life expectancy in those affected, thus efficacious treatment is key. Endothelin 1 (ET-1) and angiotensin…

31 Oct 2024

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.

Loading posts...

1 2 3 … 20 Next »